Uncategorized Guest User 5/23/14 Uncategorized Guest User 5/23/14 The House and Senate Speak. Details Still to Come. Read More Advocacy at a Glance Guest User 5/23/14 Advocacy at a Glance Guest User 5/23/14 House Action Now Started, Continues Next Week and more Read More Uncategorized Guest User 5/21/14 Uncategorized Guest User 5/21/14 “FDA’s Responsibilities Require Significantly More Funding” Read More Uncategorized Guest User 5/16/14 Uncategorized Guest User 5/16/14 A Q&A About Expectations for FY 15 Read More Advocacy at a Glance Guest User 5/16/14 Advocacy at a Glance Guest User 5/16/14 Appropriations Subcommittee Mark-ups Scheduled for May 20 and more Read More Advocacy at a Glance Guest User 5/11/14 Advocacy at a Glance Guest User 5/11/14 House Committee Votes on Subcommittee 302(b) Allocations and more Read More Uncategorized Guest User 5/11/14 Uncategorized Guest User 5/11/14 Better Laws, Clearer Policies, and More Benefit for the Health of Americans Read More Uncategorized Guest User 5/2/14 Uncategorized Guest User 5/2/14 It's Been a Busy April at the FDA Read More Advocacy at a Glance Guest User 5/2/14 Advocacy at a Glance Guest User 5/2/14 Join Us Next Week: Freshman and Sophomore Hill Days, May 6-7 and more Read More Uncategorized Guest User 4/25/14 Uncategorized Guest User 4/25/14 Ninety Years of Regulatory Evolution: From 1924 to 2014 Read More Advocacy at a Glance Guest User 4/25/14 Advocacy at a Glance Guest User 4/25/14 Commissioner Hamburg’s Thoughts on Her 5-Year Tenure and more Read More Uncategorized Guest User 4/19/14 Uncategorized Guest User 4/19/14 No One's Talking Till 302(b) Allocations Get Made Read More Advocacy at a Glance Guest User 4/19/14 Advocacy at a Glance Guest User 4/19/14 FDA’s China Efforts Described and more Read More Uncategorized Guest User 4/11/14 Uncategorized Guest User 4/11/14 Advocating for Funding of ALL of FDA Read More Advocacy at a Glance Guest User 4/11/14 Advocacy at a Glance Guest User 4/11/14 Timing of Appropriations and more Read More Uncategorized Guest User 4/4/14 Uncategorized Guest User 4/4/14 Where Does $225 Million Come From for FY 15? Read More Advocacy at a Glance Guest User 4/4/14 Advocacy at a Glance Guest User 4/4/14 Threat from House FY 15 Budget Resolution Real and more Read More Advocacy at a Glance Guest User 4/4/14 Advocacy at a Glance Guest User 4/4/14 Commissioner Hamburg Testifies Before House Subcommittee and more Read More Uncategorized Guest User 4/4/14 Uncategorized Guest User 4/4/14 Questions and Answers About the FDA's FY 15 Budget Read More Uncategorized Guest User 3/21/14 Uncategorized Guest User 3/21/14 Alliance Hill Day: Important Feedback to Members Read More Newer Posts Older Posts
Uncategorized Guest User 5/23/14 Uncategorized Guest User 5/23/14 The House and Senate Speak. Details Still to Come. Read More
Advocacy at a Glance Guest User 5/23/14 Advocacy at a Glance Guest User 5/23/14 House Action Now Started, Continues Next Week and more Read More
Uncategorized Guest User 5/21/14 Uncategorized Guest User 5/21/14 “FDA’s Responsibilities Require Significantly More Funding” Read More
Uncategorized Guest User 5/16/14 Uncategorized Guest User 5/16/14 A Q&A About Expectations for FY 15 Read More
Advocacy at a Glance Guest User 5/16/14 Advocacy at a Glance Guest User 5/16/14 Appropriations Subcommittee Mark-ups Scheduled for May 20 and more Read More
Advocacy at a Glance Guest User 5/11/14 Advocacy at a Glance Guest User 5/11/14 House Committee Votes on Subcommittee 302(b) Allocations and more Read More
Uncategorized Guest User 5/11/14 Uncategorized Guest User 5/11/14 Better Laws, Clearer Policies, and More Benefit for the Health of Americans Read More
Uncategorized Guest User 5/2/14 Uncategorized Guest User 5/2/14 It's Been a Busy April at the FDA Read More
Advocacy at a Glance Guest User 5/2/14 Advocacy at a Glance Guest User 5/2/14 Join Us Next Week: Freshman and Sophomore Hill Days, May 6-7 and more Read More
Uncategorized Guest User 4/25/14 Uncategorized Guest User 4/25/14 Ninety Years of Regulatory Evolution: From 1924 to 2014 Read More
Advocacy at a Glance Guest User 4/25/14 Advocacy at a Glance Guest User 4/25/14 Commissioner Hamburg’s Thoughts on Her 5-Year Tenure and more Read More
Uncategorized Guest User 4/19/14 Uncategorized Guest User 4/19/14 No One's Talking Till 302(b) Allocations Get Made Read More
Advocacy at a Glance Guest User 4/19/14 Advocacy at a Glance Guest User 4/19/14 FDA’s China Efforts Described and more Read More
Uncategorized Guest User 4/11/14 Uncategorized Guest User 4/11/14 Advocating for Funding of ALL of FDA Read More
Advocacy at a Glance Guest User 4/11/14 Advocacy at a Glance Guest User 4/11/14 Timing of Appropriations and more Read More
Uncategorized Guest User 4/4/14 Uncategorized Guest User 4/4/14 Where Does $225 Million Come From for FY 15? Read More
Advocacy at a Glance Guest User 4/4/14 Advocacy at a Glance Guest User 4/4/14 Threat from House FY 15 Budget Resolution Real and more Read More
Advocacy at a Glance Guest User 4/4/14 Advocacy at a Glance Guest User 4/4/14 Commissioner Hamburg Testifies Before House Subcommittee and more Read More
Uncategorized Guest User 4/4/14 Uncategorized Guest User 4/4/14 Questions and Answers About the FDA's FY 15 Budget Read More
Uncategorized Guest User 3/21/14 Uncategorized Guest User 3/21/14 Alliance Hill Day: Important Feedback to Members Read More